...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024

guess these folks below didn't see your memo - the more u flap the more you sound like mccafray- take a break , you'd swear u we're 20 -30 years old & have another 20-30 years to wait on this clown to accomplish something significant!

13 million for both company's to move the science forward & u give donnys plan moving forward an 8 out of ten. Delusional imho.

 Below is what Don accomplished today with his rose colored glasses. What flop! This is where we're at? What "discussion" has he been in & with & who. Reaching out for bread crumbs like a cornered rat imo.

 

DATE
TIMESTAMP
PRICE
VOLUME
09/25/2024 12:03:01
0.000001
7,680
Share
New Message
Please login to post a reply